The activation of TLR4 further stimulates nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, increasing reactive oxygen species (ROS) production, which in turn inhibits endothelial nitric oxide synthase (eNOS) activity, thereby contributing to endothelial dysfunction, vascular inflammation, and hypertension. The gene discussed is NOS3; the disease is endothelial dysfunction.